We learned not long ago that Google is acquiring Fitbit. It’s easy to see why. Data and users may sound like the main consideration for this deal, but there is more at play. Hardware meets software Over the last several years, Google has shown its
Much is talked about health care distribution channels such as payers here in the US. Yet just across the atlantic, there is a payer that is just as important especially when it comes to testing new AI ideas – the UK National Health Service (NHS).
Livongo and Health Catalyst made the public markets late last month, showcasing how the market in terms of VC and customer acquisition for B2B healthcare and the wider tech industry will likely adapt. On the surface both companies may look like healthcare companies but on
The World Medical Innovation Forum in Boston just wrapped after three days of insights on artificial intelligence in health care. While it didn’t disappoint in respect to buzzwords as is expected in AI conferences, it was the quality of the participants and their views on
Data interoperability is the flavor of the month. Everyone is working on it. Different EHR providers mean ‘proprietary data’ and impact to revenue hence naturally system A can’t talk to system B when patient changes health plan, provider or employer benefits Apple may be bringing
Considering the launch of a Bayer campaign back in 2016 reported by Fierce Pharma, Facebook has been building teams that sell pharma ads to the health care sector. While still in the early stages, it is no secret that Google built those teams years ago